2026-07-032 min
Ipamorelin: Endpoint Hierarchy and Evidence Boundaries
An evidence-led Ipamorelin review focused on endpoint hierarchy, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity DeskEditorial desk
Sports Integrity Desk
Anti-Doping Research EditorsThe Sports Integrity Desk explains current WADA rules and the implications of peptide-hormone prohibitions for tested athletes.
34 published notesEvidence notes
Open
2026-06-262 min
Modified GRF (1-29): Endpoint Hierarchy and Evidence Boundaries
An evidence-led Modified GRF (1-29) review focused on endpoint hierarchy, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity Desk2026-06-242 min
CJC-1295 DAC: Research Gaps Map and Evidence Boundaries
An evidence-led CJC-1295 DAC review focused on research gaps map, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity Desk2026-06-212 min
CJC-1295 DAC: FDA Status Explained and Evidence Boundaries
An evidence-led CJC-1295 DAC review focused on fda status explained, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity Desk2026-06-212 min
CJC-1295 DAC: Immunogenicity Questions and Evidence Boundaries
An evidence-led CJC-1295 DAC review focused on immunogenicity questions, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity Desk2026-06-202 min
CJC-1295 DAC: Safety Signal Review and Evidence Boundaries
An evidence-led CJC-1295 DAC review focused on safety signal review, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity Desk2026-06-192 min
CJC-1295 DAC: Receptor Pathway Map and Evidence Boundaries
An evidence-led CJC-1295 DAC review focused on receptor pathway map, human-study limits, regulatory context and claim verification.
Reviewed by Sports Integrity Desk